Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asfotase alfa in infants and young children with hypophosphatasia
2010-019850-42Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Oct 2010
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Primary endpoint: Effect of asfotase alfa treatment on skeletal manifestations of hypophosphatasia using Radiographic Global Impression of Change. Started Oct 2010; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on 2010-019850-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019850-42.